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Introduction
Heart failure is a deadly disease affecting over 20 million people worldwide. This vast 
prevalence of heart disease looms the prevalence of cancer and presents a serious societal 
burden. Though we are currently striving to find new therapeutic strategies to treat heart failure 
patients, we are currently still struggling to understand the intricate changes that occur in the 
diseased myocardium in response to injury. Complete understanding of the intricate biology 
of the cardiac extracellular matrix in relation to heart failure development may prevail novel 
inputs to treat and cure this disease. In particular comprehending the close interaction of the 
cardiac extracellular matrix with the immune system as immunity is one of the driving forces 
behind adverse cardiac remodeling hence heart failure development.
In this thesis I demonstrate that the cardiac extracellular matrix is a very dynamic entity that 
is continuously changing and adapting towards its environment (Chapter 3). The constantly 
adapting appearance of the extracellular matrix is illustrated by small leucine rich proteoglycan 
Osteoglycin (Chapter  4) in myocardial infarction versus viral myocarditis. That extracellular 
proteins are vital for regulating tissue homeostasis is illustrated by the novel role of glycoprotein 
SPARC in the microvascular glycocalyx where it regulates cardiac inflammation (Chapter 5). 
Not only recruitment of immune cells can be controlled by the extracellular environment, 
also the clearance of inflammation is under control of the production of versatile extracellular 
glycoproteins and proteoglycans. Demonstrative of this is the influence of semaphorin 3A 
on the clearance of pro-inflammatory M1 macrophages during myocardial infarct healing as 
illustrated in Chapter 6. This thesis therefore highlights novel imperative knowledge on how 
the ever-changing cardiac extracellular matrix regulates inflammation in cardiac disease. 
The Extracellular Matrix: my ‘Heart’ to Society
Fundamental knowledge on versatile extracellular matrix proteins in relation to cardiac 
inflammation exhibits a novel platform for heart failure drug development. Though drug 
discovery is needed for improving the treatment of heart failure patients, unravelling all 
biological aspects of this disease entity proceeds in time. As a clinician I feel we should value the 
significance of fundamental research for this purpose. Creating knowledge without thinking 
about practical applications is what science is all about. The pursuit for complete understanding 
of human biology in health and disease is imperative for drug discovery. Indeed, where micro-
RNAs have already disclosed a novel layer of biological complexity in cardiac disease in the 
early nineties thereby introducing a tremendous nursery for drug discovery, I believe this thesis 
suggests that the the ever-changing and versatile proteoglycans and glycoproteins residing in 
the extracellular matrix impose even greater therapeutic potential.  
Science communication
As a clinician and person I feel strongly about clear, open and vociferous communication 
on our fundamental scientific findings to a layman’s audience. I feel the general public should 
be informed about the importance of fundamental biological discoveries in order to appreciate 
its relevance and value for the eventual drug discovery and development.  If we can go on this 
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quest together by increasing the commitment and involvement of society, the chance of finding 
that one cure for heart failure might be closer than we think. In this thesis I have tried to gather 
all the necessary expertise that was needed to unravel the intricacy of the studied proteins. 
Not only these collaborations but also conferences allow for attaining feedback from experts 
in the field on the obstacles one faces when unraveling the multifariousness of glycobiology. 
The feedback that I have received has helped me in formulating sharp hypothesis thereby 
facilitating the quest for answers. Fortunately this process work two ways as my presentations 
on conferences has also resulted in increased attention for the importance yet intricacy of 
glycobiology in the heart. This collective search for novel therapeutic strategies in cardiology is 
presented by this thesis and will hopefully aid heart failure drug development.  
The Extracellular Matrix: from Mice to Man
Because the level of complexity of the extracellular matrix takes precedence over that of 
micro-RNA biology, unraveling the appearance of this ever-changing extracellular structure 
is challenging. Untying all players in the extracellular compartment and assigning individual 
value to each of them in the seemingly chaotic series of events that occur during disease, 
may help in finding an entrance to influence the outcome of the disease.  However, where 
does one start with such an overwhelming endeavor. As we currently lack the technology to 
create biologically identical robots to mimic our human diseases, at present we still use animal 
models for this purpose. The fact that heart disease is a highly complex illness where many 
factor contribute to disease progression and outcome doesn’t allow us to use cell culture or 
in silico calculation to study its pathophysiology. Nevertheless, we should strive for reducing 
and replacing the use of animals for scientific purposes by stimulating collaborations with 
researchers all over the world. 
Translation to other Fields
While inflammation is a major contributor to cardiac disease development and progression, 
it is certainly nog exclusive to the myocardium. Indeed, one of the most intriguing aspects of 
studying inflammation is the multiplicity of the inflammatory mediators that are constantly 
being discovered, like microRNAs, adipokines, inflammasomes and the danger signals like 
extracellular glycoproteins and proteoglycans. Interestingly, their effect on target tissues 
seems very universal and numerous studies have demonstrated that inflammatory responses 
represent the ‘common soil’ of the multifactorial diseases, covering both chronic inflammatory 
rheumatic disorders as well as an extensive range of conditions including cardiovascular disease, 
neurodegenerative diseases, type 2 diabetes, obesity, asthma, ageing and cancer. Therefore, this 
thesis unravels novel inflammatory mediators that influence cardiac inflammation, hence are 
likely to involve general inflammatory responses.
Conclusion
Heart failure is a tremendous societal burden and current therapies are mainly supportive. 
Hence, there is real need for finding new therapeutic strategies. Where micro-RNAs have 
already opened the stage for novel drug discovery, extracellular glycoproteins and proteoglycans 
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are an even greater nursery for heart failure drug discovery. Fundamental findings as described 
in this thesis are vital in this search. Not only in cardiovascular disease do extracellular 
glycoproteins and proteoglycans present novel treatment possibilities, numerous diseases could 
benefit the multiplicity of the novel inflammatory mediators described in this thesis.  Finally, 
as a clinician, I would like to emphasize that this thesis shows that fundamental research is an 
inseparable keystone in drug discovery.
